Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tissue Regeneration Systems Inc.

Latest From Tissue Regeneration Systems Inc.

M&A Analysis: April Showers Big Name Acquisitions

M&A deals rained down in April with the highest number of acquisitions of the year to date. The month saw 14 M&A deals, up by four from March's total, but still down from the 16 deals recorded in April 2016.

M & A Deals

3D Printing: Will Personalized Medical Devices Be The Next Big Thing?

Medical device manufacturers have a growing interest in 3D printing, a technology that could upend the manufacturing and distribution of certain medical devices and expand the scope of personalized medicine – especially in orthopedics, where it's used for some models, implants, and surgical cutting guides. Despite uncertainties related to regulation, reimbursement, and scaling up, global 3D printing revenues for medical and dental applications reached an estimated $537.1 million in 2014.

Medical Device North America

Medtech Execs On The Move, February 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

3-D Printed Implants Hit The Market, Pave The Way For More Personalized Devices

Companies have recently started to launch implants constructed via 3-D printing to increase product customization and to save on costs. FDA says the additive manufacturing techniques are a promising form of personalized medicine.

Medical Device Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Tissue Regeneration Systems Inc.
  • Senior Management
  • Jim Fitzsimmons, Pres. & CEO
    Sharon Schulzki, SVP, Bus. Dev.
  • Contact Info
  • Tissue Regeneration Systems Inc.
    Phone: (734) 274-2904
    Ann Arbor, MI
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register